Amneal Pharmaceuticals Inc Class A (AMRX)
Investing Cash Flow
-$212.37M
TTM · Period ending: · USD
AMRX Investing Cash Flow
Latest reported-$212.37Mperiod ending
Latest reported-$212.37Mperiod ending
AMRX TTM Cash from Investing (-$98.55M → -$212.37M)
TTM investing cash flow
High-resolution chart · PNG
AMRX investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -212,370,000 | |
| -116,175,000 | |
| -112,263,000 | |
| -82,868,000 | |
| -81,116,000 | |
| -61,034,000 | |
| -62,996,000 | |
| -78,629,000 | |
| -71,393,000 | |
| -77,212,000 | |
| -69,189,000 | |
| -48,963,000 | |
| -84,819,000 | |
| -88,651,000 | |
| -174,309,000 | |
| -249,812,000 | |
| -212,113,000 | |
| -278,884,000 | |
| -194,182,000 | |
| -139,008,000 | |
| -142,157,000 | |
| -68,197,000 | |
| -317,546,000 | |
| -290,518,000 | |
| -245,754,000 | |
| -260,156,000 | |
| -19,580,000 | |
| -9,492,000 | |
| -80,249,000 | |
| -398,345,000 | |
| -396,378,000 | |
| -410,600,000 | |
| -404,866,000 | |
| -93,296,000 | |
| -98,554,000 | |
| -125,716,000 |